The clinical relevance of OSM in inflammatory diseases: a comprehensive review by Cody L. Wolf, Clyde Pruett, Darren Lighter, Cheryl L. Jorcyk, Cheryl L. Jorcyk

Get full text

Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer by Joe Christianson, Joe Christianson, Julia Thom Oxford, Julia Thom Oxford, Cheryl L. Jorcyk, Cheryl L. Jorcyk

Get full text

Development of PIN and Prostate Adenocarcinoma Cell Lines: A Model System for Multistage Tumor Progression by Colin R. Soares, Masa-Aki Shibata, Jeffrey E. Green, Cheryl L. Jorcyk

Get full text

The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. by Jake Goyden, Ken Tawara, Danielle Hedeen, Jeffrey S Willey, Julia Thom Oxford, Cheryl L Jorcyk

Get full text

Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment by Simion C. Dinca, Daniel Greiner, Keren Weidenfeld, Laura Bond, Dalit Barkan, Cheryl L. Jorcyk

Get full text

9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model by Nilufar Ali, Cody Wolf, Swarna Kanchan, Shivakumar R. Veerabhadraiah, Laura Bond, Matthew W. Turner, Cheryl L. Jorcyk, Greg Hampikian

Get full text

Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery by Olga A. Mass, Joseph Tuccinardi, Luke Woodbury, Cody L. Wolf, Bri Grantham, Kelsey Holdaway, Xinzhu Pu, Matthew D. King, Don L. Warner, Cheryl L. Jorcyk, Lisa R. Warner

Get full text